Wednesday, October 24, 2018

Pre-Conference "Women´s Health Summit: Cardiometabolic Health Across the Lifespan"

10:30 - 10:40 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

10:40 - 11:10 am

Cardio-oncology: An emerging field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

12:00 - 1:00 pm

PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.

1:10 - 1:15 pm

Welcome Back to Women’s Health Summit

Pamela B. Morris, MD

1:15 - 1:45 pm

Cardiometabolic Risk in PCOS and Implications for Management

Andrea E. Dunaif, MD

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

2:15 - 2:30 pm

Nutrition Break

2:30 - 3:00 pm

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Nieca Goldberg, MD

3:00 - 3:30 pm

Updates on the Role of Postmenopausal Hormone Replacement Therapy

JoAnn E. Manson, MD, DrPH, FAHA

3:30 - 3:50 pm

Women’s Health Summit Expert Panel Discussion and Q&A

Chair: Pamela B. Morris, MD

Panelists: Andrea E. Dunaif, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA

3:50 - 4:00 pm

Conclusions to CMHC Women’s Health Summit

Pamela B. Morris, MD

4:00 - 4:15 pm

Mini Break

4:15 - 5:15 pm

PME Light Bites Session (Non-CME)

Gaining Access to PCSK9 Inhibitors: Using a Novel Mobile App
Seth J. Baum, MD, FASPC; Howard S. Weintraub, MD, FASPC

Sponsored by the American Society for Preventive Cardiology

5:30 - 6:30 pm

PME Light Bites Session (Non-CME)

Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.

6:45 - 7:45 pm

PME Dinner Symposium (Non-CME)

Cardiovascular Disease Burden in the US and Clinical Evaluation of VASCEPA® (icosapent ethyl)

Robert S. Busch, MD, FACE

Sponsored by Amarin Pharma, Inc.

Thursday, October 25, 2018

CMHC General Sessions

Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

The Role of CGM in Individualization of T2DM Management

Chair: Anne L. Peters, MD

Presenter: Irl B. Hirsch, MD

Supported by educational grants from Dexcom, Inc. and Medtronic.

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

KEYNOTE

C. Ronald Kahn, MD

10:15 - 11:15 am

Morning Break - Exhibit Hall

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

This session is supported by an educational grant from Novo Nordisk.

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression

Chair: Matthew R. Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:10 - 1:25 pm

CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges

Chair: JoAnn Lindenfeld, MD

Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 3:50 pm

How Many GLP-1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair: Jay S. Skyler, MD

Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD

5:10 - 6:10 pm

Welcome Reception - Exhibit Hall

6:10 - 7:10 pm

PME Light Bites Session (Non-CME)

Sponsored by Akcea Therapeutics

7:15 - 8:30 pm

CME Dinner Symposium

Mastering the Prior Authorization Process to Meet Patient Needs

Chair: Pamela B. Morris, MD

Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD

Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

Friday, October 26, 2018

CMHC General Sessions

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium A

The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients

Chair: Keith C. Ferdinand, MD

Faculty: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA

Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).

6:30 - 7:45 am

CME Breakfast Symposium B

Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice

Chair:

Faculty:

Supported by educational grants from AstraZeneca and Novo Nordisk.

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:00 - 8:45 am

Interventional Cardiology Delivered with a Fork

Stephen Devries, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

10:00 - 11:00 am

Morning Break - Exhibit Hall

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

12:00 - 1:15 pm

CME Lunch Symposium A
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: tbd

Presenters: Gurusher Panjrath, MD

Supported by an educational grant from American Regent.

12:00 - 1:15 pm

CME Lunch Symposium B
New Developments in Type 2 Diabetes Treatment to Decrease the Risk of Hypoglycemia

Chair: Robert E. Ratner, MD

Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD

Supported by an educational grant from Sanofi US.

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:25 - 1:30 pm

Opening Remarks
Christie M. Ballantyne, MD

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 4:10 pm

How Aggressively Do We Lower LDL-C and for Which Patients?

Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

6:05 - 7:05 pm

Closing Reception - Exhibit Hall

7:15 - 8:15 pm

PME Dinner Symposium (Non-CME)

Advancements in the Management of Patients with Type 2 Diabetes: Results from a Large Cardiovascular Outcomes Trial
Ronald D’Agostino, DO, FACC, FACP

Sponsored by Novo Nordisk

Saturday, October 27, 2018

CMHC General Sessions

Session IV: Hypertension, Cardio-renal, and Heart Failure

6:30 - 7:45 am

CME Breakfast Symposium
Finding the Balance: Treatment and Management of Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Chair: George L. Bakris, MD

Supported by an educational grant from Relypsa, Inc.

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

William B. White, MD

9:30 - 9:45 am

Nutrition Break

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Aldo Peixoto, MD; William B. White, MD; Keith C. Ferdinand, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Peter A. McCullough, MD

11:15 - 11:25 am

Mini Break

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks

George L. Bakris, MD

Wednesday, October 24

Pre-Conference
"Women´s Health Summit: Cardiometabolic Health Across the Lifespan"

10:30 - 10:40 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

10:40 - 11:10 am

Cardio-oncology: An emerging field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

12:00 - 1:00 pm

PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.

1:10 - 1:15 pm

Welcome Back to Women’s Health Summit

Pamela B. Morris, MD

1:15 - 1:45 pm

Cardiometabolic Risk in PCOS and Implications for Management

Andrea E. Dunaif, MD

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

2:15 - 2:30 pm

Nutrition Break

2:30 - 3:00 pm

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Nieca Goldberg, MD

3:00 - 3:30 pm

Updates on the Role of Postmenopausal Hormone Replacement Therapy

JoAnn E. Manson, MD, DrPH, FAHA

3:30 - 3:50 pm

Women’s Health Summit Expert Panel Discussion and Q&A

Chair: Pamela B. Morris, MD

Panelists: Andrea E. Dunaif, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA

3:50 - 4:00 pm

Conclusions to CMHC Women’s Health Summit

Pamela B. Morris, MD

4:00 - 4:15 pm

Mini Break

4:15 - 5:15 pm

PME Light Bites Session (Non-CME)

Gaining Access to PCSK9 Inhibitors: Using a Novel Mobile App
Seth J. Baum, MD, FASPC; Howard S. Weintraub, MD, FASPC

Sponsored by the American Society for Preventive Cardiology

5:30 - 6:30 pm

PME Light Bites Session (Non-CME)

Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.

6:45 - 7:45 pm

PME Dinner Symposium (Non-CME)

Cardiovascular Disease Burden in the US and Clinical Evaluation of VASCEPA® (icosapent ethyl)

Robert S. Busch, MD, FACE

Sponsored by Amarin Pharma, Inc.

Thursday, October 25, 2018

Session I: Diabetes Management

3:50 PM - 5:05 PM

Multidisciplinary Case Consults

Chair: Jay S. Skyler, MD

Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BC-ADM; Anne L. Peters, MD; Irl B. Hirsch, MD

Friday, October 26, 2018

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

5:00 PM - 6:00 PM

Multidisciplinary Case Consults

Chair: Christie M. Ballantyne, MD

Panelists: Vera A. Bittner, MD; Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

Thursday, October 25, 2018

Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

The Role of CGM in Individualization of T2DM Management

Chair: Anne L. Peters, MD

Presenter: Irl B. Hirsch, MD

Supported by educational grants from Dexcom, Inc. and Medtronic.

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression

Chair: Matthew R. Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

12:10 - 1:25 pm

CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges

Chair: JoAnn Lindenfeld, MD

Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

7:15 - 8:30 pm

CME Dinner Symposium

Mastering the Prior Authorization Process to Meet Patient Needs

Chair: Pamela B. Morris, MD

Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD

Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium A

The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients

Chair: Keith C. Ferdinand, MD

Faculty: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA

Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).

12:00 - 1:15 pm

CME Lunch Symposium A
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: tbd

Presenters: Gurusher Panjrath, MD

Supported by an educational grant from American Regent.

12:00 - 1:15 pm

CME Lunch Symposium B
New Developments in Type 2 Diabetes Treatment to Decrease the Risk of Hypoglycemia

Chair: Robert E. Ratner, MD

Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD

Supported by an educational grant from Sanofi US.

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Saturday, October 27, 2018

Session IV: Hypertension, Cardio-renal, and Heart Failure

6:30 - 7:45 am

CME Breakfast Symposium
Finding the Balance: Treatment and Management of Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease

Chair: George L. Bakris, MD

Supported by an educational grant from Relypsa, Inc.

Thursday, October 25, 2018

10:15 - 11:15 am

Morning Break - Exhibit Hall

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

Friday, October 26, 2018

10:00 - 11:00 am

Morning Break - Exhibit Hall

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

Saturday, October 27, 2018

11:15 AM - 11:25 AM

Mini Break

Thursday, October 25, 2018

Session I: Diabetes Management

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

KEYNOTE

C. Ronald Kahn, MD

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

This session is supported by an educational grant from Novo Nordisk.

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

3:20 - 3:50 pm

How Many GLP-1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair: Jay S. Skyler, MD

Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

Friday, October 26, 2018

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

3:20 PM - 4:10 PM

How Aggressively do we Lower LDL-C and for Which Patients?

Vera A. Bittner, MD

Marc S. Sabatine, MD

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

Friday, October 26, 2018

Session IV: Hypertension, Cardio-renal, and Heart Failure

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

tbd

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Aldo Peixoto, MD; tbd; Keith C. Ferdinand, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Peter A. McCullough, MD

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks

George L. Bakris, MD

Thursday, October 25, 2018

Session I: Diabetes Management

9:30 AM - 10:15 AM

Keynote

C. Ronald Kahn, MD

Thursday, October 25, 2018

Session I: Diabetes Management

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

Wednesday, October 24, 2018

Pre-Conference "Women´s Health Summit: Cardiometabolic Health Across the Lifespan"

4:15 - 5:15 pm

PME Light Bites Session (Non-CME)

Gaining Access to PCSK9 Inhibitors: Using a Novel Mobile App
Seth J. Baum, MD, FASPC; Howard S. Weintraub, MD, FASPC

Sponsored by the American Society for Preventive Cardiology

5:30 - 6:30 pm

PME Light Bites Session (Non-CME)

Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.

6:45 - 7:45 pm

PME Dinner Symposium (Non-CME)

Cardiovascular Disease Burden in the US and Clinical Evaluation of VASCEPA® (icosapent ethyl)

Robert S. Busch, MD, FACE

Sponsored by Amarin Pharma, Inc.

Thursday, October 25, 2018

Session I: Diabetes Management

7:40 PM - 8:40 PM

PME Dinner Symposium (Non-CME)

Faculty TBD

Sponsored by Akcea Therapeutics

Friday, October 26, 2018

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

7:15 PM - 8:15 PM

PME Dinner Symposium (Non-CME)

Faculty TBD

Sponsored by Novo Nordisk.

Thursday, October 25, 2018

5:10 - 6:10 pm

Welcome Reception - Exhibit Hall

Christie M. Ballantyne, MD;

Robert H. Eckel, MD;

Jay S. Skyler, MD

Friday, October 26, 2018

6:05 - 7:05 pm

Closing Reception - Exhibit Hall

Christie M. Ballantyne, MD;

Robert H. Eckel, MD

Thursday, October 25, 2018

Session I: Diabetes Management

7:15 - 8:30 pm

CME Dinner Symposium

Mastering the Prior Authorization Process to Meet Patient Needs

Chair: Pamela B. Morris, MD

Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD

Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium A

The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients

Chair: Keith C. Ferdinand, MD

Faculty: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA

Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).

Wednesday, October 24, 2018

Pre-Conference "Women´s Health Summit: Cardiometabolic Health Across the Lifespan"

<

10:40 - 11:10 am

Cardio-oncology: An emerging field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

Wednesday, October 24, 2018

Pre-Conference "Women´s Health Summit: Cardiometabolic Health Across the Lifespan"

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

Thursday, October 25, 2018

Session I: Diabetes Management

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium B

Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice

Chair:

Faculty:

Supported by educational grants from AstraZeneca and Novo Nordisk.

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

Thursday, October 25, 2018

Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

The Role of CGM in Individualization of T2DM Management

Chair: Anne L. Peters, MD

Presenter: Irl B. Hirsch, MD

Supported by educational grants from Dexcom, Inc. and Medtronic.

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

KEYNOTE

C. Ronald Kahn, MD

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

This session is supported by an educational grant from Novo Nordisk.

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression

Chair: Matthew R. Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

3:20 - 3:50 pm

How Many GLP-1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair: Jay S. Skyler, MD

Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

12:00 - 1:15 pm

CME Lunch Symposium B
New Developments in Type 2 Diabetes Treatment to Decrease the Risk of Hypoglycemia

Chair: Robert E. Ratner, MD

Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD

Supported by an educational grant from Sanofi US.

Thursday, October 25, 2018

Session I: Diabetes Management

12:10 - 1:25 pm

CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges

Chair: JoAnn Lindenfeld, MD

Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

12:00 - 1:15 pm

CME Lunch Symposium A
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: tbd

Presenters: Gurusher Panjrath, MD

Supported by an educational grant from American Regent.

Saturday, October 27, 2018

Session IV: Hypertension, Cardio-renal, and Heart Failure

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Peter A. McCullough, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:55 - 1:00 pm

Closing Remarks

George L. Bakris, MD

Thursday, October 25, 2018

Session I: Diabetes Management

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

Saturday, October 27, 2018

Session IV: Hypertension, Cardio-renal, and Heart Failure

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

tbd

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Aldo Peixoto, MD; tbd; Keith C. Ferdinand, MD

12:55 - 1:00 pm

Closing Remarks

George L. Bakris, MD

Thursday, October 25, 2018

Session I: Diabetes Management

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

Friday, October 26, 2018

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:25 - 1:30 pm

Opening Remarks
Christie M. Ballantyne, MD

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.

3:20 - 4:10 pm

How Aggressively Do We Lower LDL-C and for Which Patients?

Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

8:00 - 8:45 am

Interventional Cardiology Delivered with a Fork

Stephen Devries, MD

Thursday, October 25, 2018

Session I: Diabetes Management

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair: Christie M. Ballantyne, MD

Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH

Friday, October 26, 2018

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

Thursday, October 25, 2018

Session I: Diabetes Management

12:10 - 1:25 pm

CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression

Chair: Matthew R. Weir, MD

Presenters: Lance Sloan, MD; Robert D. Toto, MD

Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

Saturday, October 27, 2018

Session IV: Hypertension, Cardio-renal, and Heart Failure

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks

George L. Bakris, MD

Wednesday, October 24, 2018

Pre-Conference "Women's Health Summit: Cardiometabolic Health Across the Lifespan"

10:30 - 10:40 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

10:40 - 11:10 am

Cardio-oncology: An emerging field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

1:10 - 1:15 pm

Welcome Back to Women’s Health Summit

Pamela B. Morris, MD

1:15 - 1:45 pm

Cardiometabolic Risk in PCOS and Implications for Management

Andrea E. Dunaif, MD

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

2:30 - 3:00 pm

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Nieca Goldberg, MD

3:00 - 3:30 pm

Updates on the Role of Postmenopausal Hormone Replacement Therapy

JoAnn E. Manson, MD, DrPH, FAHA

3:30 - 3:50 pm

Women’s Health Summit Expert Panel Discussion and Q&A

Chair: Pamela B. Morris, MD

Panelists: Andrea E. Dunaif, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA

3:50 - 4:00 pm

Conclusions to CMHC Women’s Health Summit

Pamela B. Morris, MD